These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23056288)

  • 1. ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysis.
    Su J; Xu J; Li X; Zhang H; Hu J; Fang R; Chen X
    PLoS One; 2012; 7(10):e46366. PubMed ID: 23056288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the
    Biswas M; Rahaman S; Biswas TK; Ibrahim B
    Expert Opin Drug Saf; 2020 Dec; 19(12):1605-1616. PubMed ID: 33040624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
    Mega JL; Close SL; Wiviott SD; Shen L; Walker JR; Simon T; Antman EM; Braunwald E; Sabatine MS
    Lancet; 2010 Oct; 376(9749):1312-9. PubMed ID: 20801494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease.
    Zhai Y; He H; Ma X; Xie J; Meng T; Dong Y; Lu J
    Eur J Clin Pharmacol; 2017 Jul; 73(7):843-854. PubMed ID: 28378058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful?
    Singh M; Shah T; Adigopula S; Molnar J; Ahmed A; Khosla S; Arora R
    Indian Heart J; 2012; 64(4):341-52. PubMed ID: 22929815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis.
    Su J; Xu H; Yang J; Yu Q; Yang S; Zhang J; Yao Q; Zhu Y; Luo Y; Ji L; Zheng Y; Yu J
    Lipids Health Dis; 2015 Oct; 14():122. PubMed ID: 26438079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between ATP-binding cassette subfamily B member 1 and cytochrome P450 2C19 polymorphisms and the effect of clopidogrel post percutaneous coronary intervention in patients with acute coronary syndrome].
    Zhou CF; Ren YH; Song YQ; Yi J; Han BS; Xue Q; Fu ZH; Li DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):309-14. PubMed ID: 27112608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
    Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
    Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention.
    Tang XF; Wang J; Zhang JH; Meng XM; Xu B; Qiao SB; Wu YJ; Chen J; Wu Y; Chen JL; Gao RL; Yuan JQ; Yang YJ
    Eur J Clin Pharmacol; 2013 May; 69(5):1103-12. PubMed ID: 23150151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis.
    Luo M; Li J; Xu X; Sun X; Sheng W
    Thromb Res; 2012 Jun; 129(6):754-9. PubMed ID: 22209339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis.
    Ma L; Ruan L; Liu H; Yang H; Feng Y
    Onco Targets Ther; 2015; 8():1009-15. PubMed ID: 25999734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
    Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
    JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis.
    Tazzite A; Kassogue Y; Diakité B; Jouhadi H; Dehbi H; Benider A; Nadifi S
    BMC Genet; 2016 Sep; 17(1):126. PubMed ID: 27580695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposure.
    Wang C; Xie L; Zhou K; Zhan Y; Li Y; Li H; Qiao L; Wang F; Hua Y
    PLoS One; 2013; 8(7):e68807. PubMed ID: 23874772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of clopidogrel and ticagrelor in patients undergoing off-pump coronary artery bypass grafting: a retrospective cohort study.
    Wang Z; Ma R; Li X; Li X; Xu Q; Yao Y; Wang C; Lv Q
    Int J Surg; 2024 Jun; 110(6):3450-3460. PubMed ID: 38445500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.
    Zhang L; Chen Y; Jin Y; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Li X; Li Y; Zhang Y; Lu C; Yin T
    Thromb Res; 2013 Jul; 132(1):81-7. PubMed ID: 23726091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention.
    Wang T; Li H; Wang F; Sun L; Yu L
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1679-1686. PubMed ID: 34164723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han.
    Wang JY; Zhang YJ; Li H; Hu XL; Li MP; Song PY; Ma QL; Peng LM; Chen XP
    Gene; 2018 Dec; 678():226-232. PubMed ID: 30096456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East Asians.
    Park MW; Her SH; Kim CJ; SunCho J; Park GM; Kim TS; Choi YS; Park CS; Koh YS; Park HJ; Kim PJ; Chung WS; Seung KB; Kim HS; Shin JG; Chang K
    Genet Med; 2016 Aug; 18(8):833-41. PubMed ID: 26699760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention.
    Calderón-Cruz B; Rodríguez-Galván K; Manzo-Francisco LA; Vargas-Alarcón G; Fragoso JM; Peña-Duque MA; Reyes-Gómez CA; Martínez-Ríos MA; De la Peña-Díaz A
    Thromb Res; 2015 Nov; 136(5):894-8. PubMed ID: 26362473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.